Chau T Dang (Chau Dang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Hypertrophic Cardiomyopathy

Positive Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

The Journal of experimental medicine

NPJ breast cancer

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Z Drago, Shanu Modi, Jacqueline F Bromberg, Chau T Dang, Dazhi Liu, Larry Norton, Mark E Robson, Sarat Chandarlapaty, Komal L Jhaveri
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer. Research square (2024)
Komal L Jhaveri, Nicholas Mai, Carlos Henrique Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Drago, Shanu Modi, Jacqueline Bromberg, Chau T Dang, Dazhi Liu, Larry Norton, Mark E Robson, Sarat Chandarlapaty
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer. Research square (2024)
Anthony F Yu, I-Hsin Lin, Justine Jorgensen, Robert Copeland-Halperin, Stephanie Feldman, Ishmam Ibtida, Amare Assefa, Michelle N Johnson, Chau T Dang, Jennifer E Liu, Richard M Steingart
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Journal of the American Heart Association (2023)
Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria R Xue, Erica L Cantor, Reynold C Ly, Wilberforce Osei, Xi Wu, Chau T Dang, Donald W Northfelt, Todd C Skaar, Kathy D Miller, George W Sledge, Bryan Paul Schneider
Cytochrome P450 oxidoreductase, POR, associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Emanuela Ferraro, Jasmeet Singh, Sujata Patil, Pedram Razavi, Shanu Modi, Sarat Chandarlapaty, Andrea V Barrio, Rachna Malani, Ingo K Mellinghoff, Adrienne A Boire, Hannah Y Wen, Edi Brogi, Andrew D Seidman, Larry Norton, Mark E Robson, Chau T Dang
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab. NPJ breast cancer 8 (1) (2022)
Chau T Dang, Michael S Ewer, Suzette Delaloge, Jean-Marc Ferrero, Ramon Colomer, Luis de la Cruz-Merino, Theresa L Werner, Katherine Dadswell, Mark Verrill, Daniel Eiger, Sriparna Sarkar, Sanne Lysbet de Haas, Eleonora Restuccia, Sandra M Swain
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. Cancers 14 (11) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau T Dang, Denise A Yardley, Steven J Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C Wolff, Katherine Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, P Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Yue Zheng, Shoshana M Rosenberg, Richard D Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann H Partridge, Eric P Winer, Ian E Krop, Sara M Tolaney
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial. NPJ breast cancer 8 (1) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)
Joseph A Sparano, Anne O'Neill, Noah Graham, Donald W Northfelt, Chau T Dang, Antonio C Wolff, George W Sledge, Kathy D Miller
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer. NPJ breast cancer 8 (1) (2022)
Sandra M Swain, Harrison Macharia, Javier Cortes, Chau T Dang, Luca Gianni, Sara A Hurvitz, Christian Jackisch, Andreas Schneeweiss, Dennis Slamon, Pinuccia Valagussa, Yolande du Toit, Dominik Heinzmann, Adam Knott, Chunyan Song, Patricia Cortazar
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. Cancers 14 (20) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)
Tal Sella, Yue Zheng, Nabihah Tayob, Kathryn J Ruddy, Rachel A Freedman, Chau T Dang, Denise Yardley, Steven Jay Isakoff, Vicente Valero, Michelle DeMeo, Harold J Burstein, Eric P Winer, Antonio C Wolff, Ian E Krop, Ann H Partridge, Sara M Tolaney
Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT). NPJ breast cancer 8 (1) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)
Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody DiBona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart, Alessandra Piersigilli, Nicholas D Socci, Angel T Chan, Anthony F Yu, Samuel F Bakhoum, Adam M Schmitt
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of experimental medicine 220 (3) (2022)